Lonza is a renowned global brand that specializes in providing integrated healthcare solutions. With a focus on preventing illness, promoting healthier lifestyles, and creating a healthy environment, Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers effectively. Lonza offers a wide range of products and services in the pharmaceutical, biotech, and nutrition markets.

From early phase discovery to custom development and manufacturing of active pharmaceutical ingredients, Lonza provides innovative dosage forms for the pharma and consumer health and nutrition industries. With its scale and resources, Lonza offers a comprehensive one-stop solution to help people get well, feel well, and stay well. Founded in 1897 in the Swiss Alps, Lonza operates across five continents and employs approximately 17,500 full-time employees.

Committed to responsible business and sustainability, Lonza aims to minimize its environmental impact and enhance life quality. Lonza's Vision Zero initiative strives for zero workplace accidents, environmental incidents, and manufacturing process incidents. In 2022 alone, Lonza supported over 825 preclinical and clinical small and large molecules, produced around 250 billion capsules, and generated sales of CHF 6.

2 billion. Lonza's shares are listed on the SIX Swiss Exchange and Swiss Market Index (SMI), with a secondary listing on the SGX Singapore Exchange